Literature DB >> 30538404

Vasoformative Lesions in Mediastinal Mixed Germ Cell Tumors: an Interesting Account of Two Cases Spanning the Benign to Malignant Spectrum.

Neha Bakshi1, Sukhram Bishnoi2, Seema Rao1.   

Abstract

Extragonadal germ cell tumors are most commonly encountered in the anterior mediastinum. The presence of sarcomatous malignancies in these tumors is a rare phenomenon that adversely impacts patient prognosis because of poor response to conventional cisplatin-based chemotherapy. Even more unusual is the presence of florid benign somatic proliferations that overshadow the germ cell component, often resulting in misdiagnosis and inappropriate management. Two young male patients aged 17 and 28 years respectively presented with mass in the anterior mediastinum. Histopathology of both cases revealed mixed germ cell tumor admixed with prominent vascular component. Interestingly, one case showed malignant vasoformative neoplasm (angiosarcoma) while in the other the vascular proliferation was of benign nature (venous hemangioma).

Entities:  

Keywords:  Angiosarcoma; Mediastinal germ cell tumor; Somatic malignancy; Vasoformative lesion

Year:  2018        PMID: 30538404      PMCID: PMC6265192          DOI: 10.1007/s13193-018-0778-y

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  8 in total

1.  Testicular germ cell tumors with sarcomatous components: an analysis of 33 cases.

Authors:  Charles C Guo; Metin Punar; Alejandro Luiña Contreras; Shi-Ming Tu; Louis Pisters; Pheroze Tamboli; Bogdan Czerniak
Journal:  Am J Surg Pathol       Date:  2009-08       Impact factor: 6.394

2.  Towards the definition of the best management and prognostic factors of teratoma with malignant transformation: a single-institution case series and new proposal.

Authors:  Andrea Necchi; Maurizio Colecchia; Nicola Nicolai; Luigi Piva; Mario Catanzaro; Davide Biasoni; Tullio Torelli; Silvia Stagni; Biagio Paolini; Angelo Milani; Roberto Salvioni
Journal:  BJU Int       Date:  2010-09-24       Impact factor: 5.588

3.  Ovarian teratomas with florid benign vascular proliferation: a distinctive finding associated with the neural component of teratomas that may be confused with a vascular neoplasm.

Authors:  Patricia M Baker; Juan Rosai; Robert H Young
Journal:  Int J Gynecol Pathol       Date:  2002-01       Impact factor: 2.762

4.  Mediastinal germ cell tumors with an angiosarcomatous component: a report of 12 cases.

Authors:  Alejandro Luiña Contreras; Metin Punar; Pheroze Tamboli; Shi-Ming Tu; Louis Pisters; Cesar Moran; Bogdan A Czerniak; Charles C Guo
Journal:  Hum Pathol       Date:  2010-02-12       Impact factor: 3.466

5.  Gonadal and extragonadal germ cell tumours in the United States, 1973-2007.

Authors:  A Stang; B Trabert; N Wentzensen; M B Cook; C Rusner; J W Oosterhuis; K A McGlynn
Journal:  Int J Androl       Date:  2012-02-09

6.  Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases.

Authors:  Hugo Domínguez Malagón; Ana María Cano Valdez; Cesar A Moran; Saul Suster
Journal:  Am J Surg Pathol       Date:  2007-09       Impact factor: 6.394

7.  Chemotherapy for teratoma with malignant transformation.

Authors:  Alessia C Donadio; Robert J Motzer; Dean F Bajorin; Philip W Kantoff; Joel Sheinfeld; Jane Houldsworth; Raju S K Chaganti; George J Bosl
Journal:  J Clin Oncol       Date:  2003-12-01       Impact factor: 44.544

8.  Exuberant Vasculoconnective Component in Mediastinal Mixed Germ Cell Tumors.

Authors:  Yoon Jin Cha; Joungho Han; Kyung Soo Lee; Young Mog Shim
Journal:  J Korean Med Sci       Date:  2015-07-15       Impact factor: 2.153

  8 in total
  2 in total

1.  Mediastinal mixed germ cell tumor: A case report and literature review.

Authors:  Xianwen Hu; Dandan Li; Jinhua Xia; Pan Wang; Jiong Cai
Journal:  Open Med (Wars)       Date:  2021-06-18

Review 2.  Pediatric mediastinal germ cell tumors.

Authors:  Aanchal Kakkar; Kavneet Kaur; Ajay Verma
Journal:  Mediastinum       Date:  2019-07-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.